• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by BIO-key International Inc. (Amendment)

    1/25/24 4:01:47 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology
    Get the next $BKYI alert in real time by email
    SC 13G/A 1 sc_13g.htm SCHEDULE 13G AMENDMENT NO. 1

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

    BIO-KEY INTERNATIONAL, INC.

    (Name of Issuer)

     

    Common Stock, $0.0001 par value per share

    (Title of Class of Securities)

     

    09060C507

    (CUSIP Number)

     

    December 31, 2023

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    [ ] Rule 13d-1(b)

     

    [X] Rule 13d-1(c)

     

    [ ] Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     


     

    CUSIP No. 09060C507

     

    1.

    Names of reporting persons.

     

    AJB Capital Investments LLC

    2.

    Check the appropriate box if a member of a group (see instructions)

     

    (a) [ ] (b) [ ]

    3. SEC use only
    4.

    Citizenship or place of organization

     

    United States

    Number of

    shares

    beneficially

    owned by

    each

    reporting

    person with:

    5.

    Sole voting power

     

    26,137 (1)

    6.

    Shared voting power

     

    0

    7.

    Sole dispositive power

     

    26,137 (1)

    8.

    Shared dispositive power

     

    0

    9.

    Aggregate amount beneficially owned by each reporting person

     

    26,137 (1)

    10.

    Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    [ ]

    11.

    Percent of class represented by amount in Item 9

     

    3.4% (2)

    12.

    Type of reporting person (see instructions)

     

    OO

     

    (1) Consists of 26,137 outstanding shares of common stock of the Issuer, par value 0.0001 (“Shares”), directly held by AJB Capital Investments LLC. AJB Capital Managers LLC is the manager of AJB Capital Investments LLC.
       
    (2) Based on 13,731,669 Shares outstanding as of November 17, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (“SEC”) on November 20, 2023, which was further adjusted to 762,870 Shares outstanding as of November 17, 2023 by the Reporting Persons to reflect the Issuer’s 18-for-1 reverse stock split as disclosed on the Issuer’s Form 8-K filed with the SEC on December 19, 2023.

     

    - 2 -


     

    CUSIP No. 09060C507

     

    1.

    Names of reporting persons.

     

    AJB Capital Managers LLC

    2.

    Check the appropriate box if a member of a group (see instructions)

     

    (a) [ ] (b) [ ]

    3. SEC use only
    4.

    Citizenship or place of organization

     

    United States

    Number of

    shares

    beneficially

    owned by

    each

    reporting

    person with:

    5.

    Sole voting power

     

    26,137 (1)

    6.

    Shared voting power

     

    0

    7.

    Sole dispositive power

     

    26,137 (1)

    8.

    Shared dispositive power

     

    0

    9.

    Aggregate amount beneficially owned by each reporting person

     

    26,137 (1)

    10.

    Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    [ ]

    11.

    Percent of class represented by amount in Item 9

     

    3.4% (2)

    12.

    Type of reporting person (see instructions)

     

    OO

     

    (1) Solely in its capacity as Manager of AJB Capital Investments LLC.
       
    (2)

    Based on 13,731,669 Shares outstanding as of November 17, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (“SEC”) on November 20, 2023, which was further adjusted to 762,870 Shares outstanding as of November 17, 2023 by the Reporting Persons to reflect the Issuer’s 18-for-1 reverse stock split as disclosed on the Issuer’s Form 8-K filed with the SEC on December 19, 2023.

     

    - 3 -


     

    ITEM 1.

     

    (A) NAME OF ISSUER:

     

    BIO-key International, Inc. (the “Issuer”)

     

    (B) ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICE:

     

    3349 Highway 138, Building A, Suite E
    Wall, NJ 07719

     

    ITEM 2.

     

    (A) NAME OF PERSONS FILING:

     

    AJB Capital Investments LLC and AJB Capital Managers LLC

     

    (B) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

     

    4700 Sheridan Street, Suite J
    Hollywood, FL 33031

     

    (C) CITIZENSHIP:

     

    Florida, United States

     

    (D) TITLE OF CLASS OF SECURITIES:

     

    Common Stock, $0.0001 par value per share

     

    (E) CUSIP NUMBER:

     

    09060C507

     

    ITEM 3. STATEMENT FILED PURSUANT TO RULE 13D-1(B) OR 13D-2(B) OR (C)

     

    Not applicable.

     

    ITEM 4. OWNERSHIP

     

    The information contained in Items 5-9 and 11 of the cover pages of this Schedule 13G is hereby incorporated by reference into this Item 4.

     

    AJB Capital Investments LLC (“AJB Investments”) is the direct owner of 26,137 shares of common stock of the Issuer, par value 0.0001 (“Shares”), constituting approximately 3.4% of the Issuer’s Shares, and has the sole power to vote and dispose of such securities.

     

    - 4 -


     

    AJB Capital Managers LLC (“AJB Managers”), in its capacity as the Manager of AJB Investments, has the ability to direct the management of the business of AJB Investments including the power to vote and dispose of securities beneficially owned by AJB Investments; therefore, AJB Managers may be deemed to have indirect beneficial ownership of the Shares held by AJB Investments.

     

    AJB Managers is managed by a board of managers (the “Board of Managers”) which operates by majority vote such that no individual member of the Board of Managers has voting or dispositive control over the Shares. Each individual constituting the Board of Managers therefore expressly disclaims beneficial ownership of these securities.

     

    Pursuant to Rule 13d-4 of the Exchange Act, the Reporting Persons declare that filing this Schedule 13G shall not be construed as an admission that any such person is, for the purposes of Section 13(d) and/or Section 13(g) of the Exchange Act, the beneficial owner of any securities covered by this Schedule 13G except to the extent of such person’s pecuniary interest in the Units, and except to the extent of its pecuniary interest, such beneficial ownership is expressly disclaimed by each Reporting Person.

     

    All calculations of percentage ownership herein are based on 13,731,669 Shares outstanding as of November 17, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (“SEC”) on November 20, 2023, which was further adjusted to 762,870 Shares outstanding as of November 17, 2023 by the Reporting Persons to reflect the Issuer’s 18-for-1 reverse stock split as disclosed on the Issuer’s Form 8-K filed with the SEC on December 19, 2023.

     

    ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [X].

     

    ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

     

    Not applicable.

     

    ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON

     

    Not applicable.

     

    ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP

     

    Not applicable.

     

    - 5 -


     

    ITEM 9. NOTICE OF DISSOLUTION OF GROUP

     

    Not applicable.

     

    ITEM 10. CERTIFICATION.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     

    SIGNATURES

     

    After reasonable inquiry and to the best of the undersigned’s knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

     

    Dated: January 25, 2024

     

    AJB CAPITAL INVESTMENTS LLC

     

    By:   AJB Capital Managers LLC, its Manager

    By:   /s/ Ari Blaine, Authorized Manager

     

    AJB CAPITAL MANAGERS LLC

     

    By:   /s/ Ari Blaine, Authorized Manager

     

     

    INDEX TO EXHIBITS

     

    Exhibit 99.1 Joint Filing Agreement, incorporated by reference to Exhibit 99.1 to the Schedule 13G filed by the Reporting Persons on January 10, 2023.

     

    - 6 -


    Get the next $BKYI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BKYI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BKYI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by BIO-key International Inc.

      SC 13G/A - BIO KEY INTERNATIONAL INC (0001019034) (Subject)

      11/14/24 5:05:04 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G filed by BIO-key International Inc.

      SC 13G - BIO KEY INTERNATIONAL INC (0001019034) (Subject)

      2/14/24 3:30:35 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by BIO-key International Inc. (Amendment)

      SC 13G/A - BIO KEY INTERNATIONAL INC (0001019034) (Subject)

      2/13/24 8:04:15 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Williams Cameron E. was granted 3,897 shares, increasing direct ownership by 33% to 15,684 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      5/12/25 4:54:08 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Director Alia Emmanuel was granted 3,897 shares, increasing direct ownership by 31% to 16,323 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      5/12/25 4:49:05 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Director Michel Robert J was granted 3,897 shares, increasing direct ownership by 29% to 17,303 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      5/12/25 4:43:34 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Financials

    Live finance-specific insights

    See more

    $BKYI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $BKYI
    SEC Filings

    See more
    • BIO-key Reports Q1'25 Revenue of $1.6M and Improved Cash Position of $3.1M; Hosts Investor Call Tomorrow, Friday May 16th at 10am ET

      HOLMDEL, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and tokenless Identity-Bound Biometric (IBB) authentication, announced results for its first quarter (Q1'25). BIO-key will host an investor call tomorrow, Friday, May 16th at 10:00am ET (details below). BIO-key CEO, Mike DePasquale commented, "Our revenue rose approximately 10% sequentially vs. Q4'24, as we continue our transition to selling high-margin BIO-key branded products in Europe, the Middle East and Africa (EMEA). Year-over-year revenue decreased 25% due to a

      5/15/25 4:15:00 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • BIO-key, Provider of Identity and Access Management Solutions Enhanced with Biometric Authentication Hosts Q1 Investor Call Fri. May 16th at 10am ET

      HOLMDEL, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management solutions with unique Identity-Bound Biometric capabilities, will host its first quarter 2025 investor call on Friday, May 16th at 10 a.m. ET. Results will be released after market close on Thursday. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and Q&A session. Call DetailsDate / Time: Friday, May 16th at 10 a.m. ETCall Dial In #:1-877-418-5460 U.S. or 1-412-717-9594 Int'lLive Webcast / Replay:Webcast & Replay Link – Available for 3 monthsAudio Replay:1-877-344-7529 U.S. or 1-412-317-0088 Int'l; code 65

      5/9/25 11:00:08 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • BIO-key Trims 2024 Net Loss 49% to $4.3M, Reflecting Higher Gross Margin and Lower Operating Costs, Offsetting 11% Revenue Decrease Due to Business Transition; Hosts Investor Call Today at 10am ET

      HOLMDEL, N.J., March 27, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced results for its fourth quarter (Q4'24) and year ended December 31, 2024 (2024). BIO-key's 2023 results, which were restated and filed with the Company's 2023 Form 10-K, are reflected in this release for comparison purposes. BIO-key will host an investor call today, Thursday, March 27th at 10:00am ET (details below). BIO-key CEO, Mike DePasquale commented, "From a strategic sta

      3/27/25 7:58:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Bio-key upgraded by Maxim Group with a new price target

      Maxim Group upgraded Bio-key from Hold to Buy and set a new price target of $6.00

      3/26/21 7:52:25 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • BIO-key International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

      8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

      5/15/25 4:46:01 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 10-Q filed by BIO-key International Inc.

      10-Q - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

      5/15/25 4:31:41 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 424B3 filed by BIO-key International Inc.

      424B3 - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

      5/12/25 4:31:59 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Depasquale Michael W bought $3,600 worth of shares (20,000 units at $0.18), increasing direct ownership by 7% to 306,827 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      12/4/23 10:12:08 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Sullivan James David bought $3,300 worth of shares (20,000 units at $0.17), increasing direct ownership by 5% to 388,171 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      12/4/23 8:35:57 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Sullivan James David bought $6,505 worth of shares (39,671 units at $0.16), increasing direct ownership by 12% to 368,171 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      11/28/23 1:35:31 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Leadership Updates

    Live Leadership Updates

    See more

    $BKYI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • BIO-key Partners with Ping Identity to Bring its Cutting-Edge Biometric Authentication to Ping Customers

      DENVER and HOMDEL, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management (IAM) solutions including Identity-Bound Biometrics, and Ping Identity, a leading provider of seamless and secure digital experiences, announced today that BIO-key's unique biometric authentication technology is now included on the Ping Identity Integration Directory. The integration enables Ping clients to utilize BIO-key's powerful and seamless biometric authentication solution in combination with the PingOne Cloud Platform. The combined solution streamlines authentication processes and ensures a secure, frictionless user experien

      12/11/23 7:59:02 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Identity and Access Management Software Provider BIO-key Names Seasoned Financial Services Executive Cameron E. Williams to its Board of Directors

      WALL, N.J., June 02, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced that it has appointed Cameron E. Williams to its Board of Directors. Mr. Williams has spent over forty years in leading executive officer roles in banking and financial services firms, serving on the board of directors of multiple organizations and more recently, in founding and leading strategic, financial and security consulting firms. Mr. Williams brings deep experience, an ideal skill set, and a broad base of relationships to his role on BIO-key

      6/2/23 8:01:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Identity and Access Management Solutions Provider BIO-key Adds Proven Security Sales Leaders in Planned Senior Management Transition

      WALL, N.J., Jan. 03, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, today announced the appointment of Galen Rodgers, Vice President of Channels, and Chad Carter, VP North America Sales. The appointments are effective today, January 3, and are in anticipation of the planned retirement of Chief Revenue Officer Fred Corsentino. A top-performing technology leader, Galen Rodgers, who will report to Chairman & CEO Michael DePasquale, brings 20+ years of experience in channel program development, marketing strategy, value selling, management, cyber security, proces

      1/3/23 8:01:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Biometric Identity and Access Management Software Solutions Provider BIO-key Announces Two Webcast Investor Presentations: Aegis Capital Thu. May 22 at 11:30am ET and Maxim Group Wed. June 4 at 11am ET

      HOLMDEL, N.J., May 20, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and tokenless, Identity-Bound Biometric (IBB) authentication solutions today announces its participation at the Aegis Capital Corp. 2025 Virtual Conference on Thursday, May 22nd and the Maxim Virtual Tech Conference on Wednesday, June 4th – webcast access details provided below. Aegis Capital Virtual Conference 2025BIO-key PresentationDate/Time: Thursday, May 22, 2025, 11:30 – 11:55 a.m. ETWebcast Link: https://us02web.zoom.us/meeting/register/AfmnLxICTqmjEvoSG9-MMQ#/reg

      5/20/25 7:59:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • BIO-key and Cloud Distribution Co. Partner to Expand IAM and Biometric Security Solutions Across the Middle East

      WALL, N.J. and RIYADH, Saudi Arabia, May 19, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication solutions, is pleased to announce a strategic partnership with Cloud Distribution Co., a prominent Value-Added Distributor (VAD) headquartered in Saudi Arabia, with operations across the Middle East. Cloud Distribution joins BIO-key's Channel Alliance Partner (CAP) program to deliver BIO-key's full suite of IAM and biometric authentication solutions to enterprises and public institutions in Saudi Arabia, the UAE, and across the region. This partnership strengthens BIO-key's local capabilities wh

      5/19/25 7:59:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • BIO-key Reports Q1'25 Revenue of $1.6M and Improved Cash Position of $3.1M; Hosts Investor Call Tomorrow, Friday May 16th at 10am ET

      HOLMDEL, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and tokenless Identity-Bound Biometric (IBB) authentication, announced results for its first quarter (Q1'25). BIO-key will host an investor call tomorrow, Friday, May 16th at 10:00am ET (details below). BIO-key CEO, Mike DePasquale commented, "Our revenue rose approximately 10% sequentially vs. Q4'24, as we continue our transition to selling high-margin BIO-key branded products in Europe, the Middle East and Africa (EMEA). Year-over-year revenue decreased 25% due to a

      5/15/25 4:15:00 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology